News & Updates
Filter by Specialty:
Show Multimedia Only

Pembrolizumab extends survival in advanced melanoma
18 Dec 2024
byStephen Padilla
Patients with advanced melanoma achieve long-term survival with the use of pembrolizumab, as shown by the results of the 10-year follow-up of the phase III KEYNOTE-006 study.
Pembrolizumab extends survival in advanced melanoma
18 Dec 2024
CV impact of COVID persists even years after infection
17 Dec 2024
byAudrey Abella
A recent study points to interesting clinical and genetic associations with COVID-19, demonstrating that the disease continues to pose a significant public health burden with lingering adverse cardiovascular (CV) risk and genetic interaction with ABO blood types.